Biontech Se Stock Price on December 20, 2024
| BNTX Stock | USD 114.13 0.62 0.55% |
Below is the normalized historical share price chart for BioNTech SE extending back to October 10, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of BioNTech stands at 114.13, as last reported on the 25th of December, with the highest price reaching 114.42 and the lowest price hitting 112.24 during the day.
If you're considering investing in BioNTech Stock, it is important to understand the factors that can impact its price. BioNTech SE secures Sharpe Ratio (or Efficiency) of -0.0086, which signifies that the company had a -0.0086% return per unit of risk over the last 3 months. BioNTech SE exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioNTech's Risk Adjusted Performance of 0.0224, mean deviation of 2.04, and Downside Deviation of 2.6 to double-check the risk estimate we provide.
At this time, BioNTech's Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 24.2 B in 2024, whereas Common Stock Total Equity is likely to drop slightly above 185.2 M in 2024. . At this time, BioNTech's Price Book Value Ratio is fairly stable compared to the past year. Price To Operating Cash Flows Ratio is likely to rise to 4.47 in 2024, whereas Price To Sales Ratio is likely to drop 5.69 in 2024. BioNTech Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of October 2019 | 200 Day MA 98.2874 | 50 Day MA 113.2494 | Beta 0.259 |
BioNTech |
Sharpe Ratio = -0.0086
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BNTX |
Estimated Market Risk
| 2.63 actual daily | 23 77% of assets are more volatile |
Expected Return
| -0.02 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average BioNTech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioNTech by adding BioNTech to a well-diversified portfolio.
Price Book 1.3736 | Enterprise Value Ebitda 110.8146 | Price Sales 8.9513 | Shares Float 91.6 M | Wall Street Target Price 136.2866 |
BioNTech Main Headline on 20th of December 2024
BioNTech Shares Down 1.3 percent Whats Next by thelincolnianonline.com
BioNTech SE shares dropped 1.3 percent on Wednesday . The stock traded as low as 115.51 and last traded at 115.91. Approximately 88,213 shares changed hands during mid-day trading, a decline of 89 percent from the average daily volume of 805,779 shares. The stock had previously closed at 117.39. Analysts Set New
BioNTech Valuation on December 20, 2024
It is possible to determine the worth of BioNTech on a given historical date. On December 20, 2024 BioNTech was worth 110.76 at the beginning of the trading date compared to the closed value of 113.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioNTech stock. Still, in general, we apply an absolute valuation method to find BioNTech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioNTech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioNTech's related companies.
| Open | High | Low | Close | Volume | |
| 111.61 | 112.32 | 109.52 | 111.34 | 958,611 | |
12/20/2024 | 110.76 | 115.34 | 109.80 | 113.08 | 924,900 |
| 112.19 | 114.46 | 112.19 | 113.51 | 413,831 |
| Backtest BioNTech | | | BioNTech History | | | BioNTech Valuation | Previous | Next |
BioNTech Trading Date Momentum on December 20, 2024
| On December 23 2024 BioNTech SE was traded for 113.51 at the closing time. The top price for the day was 114.46 and the lowest listed price was 112.19 . The trading volume for the day was 413.8 K. The trading history from December 23, 2024 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 0.38% . The overall trading delta against the current closing price is 0.25% . |
BioNTech SE Fundamentals Correlations and Trends
By evaluating BioNTech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioNTech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioNTech financial account trend analysis is a perfect complement when working with valuation or volatility modules.About BioNTech Stock history
BioNTech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioNTech is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioNTech SE will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioNTech stock prices may prove useful in developing a viable investing in BioNTech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 242.7 M | 229.1 M | |
| Net Income Applicable To Common Shares | 11.8 B | 12.4 B |
BioNTech Quarterly Net Working Capital |
|
BioNTech Stock Technical Analysis
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
BioNTech Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
BioNTech SE cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
BioNTech December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how BioNTech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioNTech shares will generate the highest return on investment. By undertsting and applying BioNTech stock market strength indicators, traders can identify BioNTech SE entry and exit signals to maximize returns
BioNTech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for BioNTech's price direction in advance. Along with the technical and fundamental analysis of BioNTech Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioNTech to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0224 | |||
| Jensen Alpha | 0.034 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.0025 | |||
| Treynor Ratio | 0.1951 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.